These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29225814)

  • 1. Perioperative Plasma-Lyte use reduces the incidence of renal replacement therapy and hyperkalaemia following renal transplantation when compared with 0.9% saline: a retrospective cohort study.
    Adwaney A; Randall DW; Blunden MJ; Prowle JR; Kirwan CJ
    Clin Kidney J; 2017 Dec; 10(6):838-844. PubMed ID: 29225814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation.
    Collins MG; Fahim MA; Pascoe EM; Dansie KB; Hawley CM; Clayton PA; Howard K; Johnson DW; McArthur CJ; McConnochie RC; Mount PF; Reidlinger D; Robison L; Varghese J; Vergara LA; Weinberg L; Chadban SJ;
    Trials; 2020 May; 21(1):428. PubMed ID: 32450917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intraoperative and early postoperative normal saline or Plasma-Lyte 148® on hyperkalaemia in deceased donor renal transplantation: a double-blind randomized trial.
    Weinberg L; Harris L; Bellomo R; Ierino FL; Story D; Eastwood G; Collins M; Churilov L; Mount PF
    Br J Anaesth; 2017 Oct; 119(4):606-615. PubMed ID: 29121282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the Type of Intraoperative Fluid in Living Donor Kidney Transplantation: A Single-Center Retrospective Cohort Study.
    Jung S; Kim J; Lee J; Choi SY; Joo HJ; Koo BN
    Yonsei Med J; 2022 Apr; 63(4):380-388. PubMed ID: 35352890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Plasma-Lyte.½ and 0.9% saline in renal function after deceased-donor kidney transplant: a randomized controlled trial.
    do Nascimento Junior P; Dohler LE; Ogawa CMU; de Andrade LÍGM; Braz LG; M Dolo NSP
    Braz J Anesthesiol; 2022; 72(6):711-719. PubMed ID: 34563559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical analysis plan for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a randomised controlled trial of the effect of intravenous fluid therapy with balanced crystalloid versus saline on the incidence of delayed graft function in deceased donor kidney transplantation.
    Pascoe EM; Chadban SJ; Fahim MA; Hawley CM; Johnson DW; Collins MG;
    Trials; 2022 Jan; 23(1):52. PubMed ID: 35042554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of 0.9% saline versus Plasma-Lyte 148 on renal function as assessed by creatinine concentration in patients undergoing major surgery: A single-centre double-blinded cluster crossover trial.
    Weinberg L; Li MH; Churilov L; Macgregor C; Garrett K; Eyles J; Bellomo R
    PLoS One; 2021; 16(5):e0251718. PubMed ID: 34010324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trial.
    Williams V; Jayashree M; Nallasamy K; Dayal D; Rawat A
    Crit Care; 2020 Jan; 24(1):1. PubMed ID: 31898531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentre randomised controlled trial: protocol for Plasma-Lyte Usage and Assessment of Kidney Transplant Outcomes in Children (PLUTO).
    Hayes W; Laing E; Foley C; Pankhurst L; Thomas H; Hume-Smith H; Marks S; Kessaris N; Bryant WA; Spiridou A; Wray J; Peters MJ
    BMJ Open; 2022 Mar; 12(3):e055595. PubMed ID: 35288387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saline versus balanced crystalloids for intravenous fluid therapy in the emergency department: study protocol for a cluster-randomized, multiple-crossover trial.
    Self WH; Semler MW; Wanderer JP; Ehrenfeld JM; Byrne DW; Wang L; Atchison L; Felbinger M; Jones ID; Russ S; Shaw AD; Bernard GR; Rice TW
    Trials; 2017 Apr; 18(1):178. PubMed ID: 28407811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal saline versus lower-chloride solutions for kidney transplantation.
    Wan S; Roberts MA; Mount P
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010741. PubMed ID: 27502170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saline versus Plasma-Lyte A in initial resuscitation of trauma patients: a randomized trial.
    Young JB; Utter GH; Schermer CR; Galante JM; Phan HH; Yang Y; Anderson BA; Scherer LA
    Ann Surg; 2014 Feb; 259(2):255-62. PubMed ID: 23732264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A protocol for the 0.9% saline versus Plasma-Lyte 148 for intensive care fluid therapy (SPLIT) study.
    Reddy SK; Bailey MJ; Beasley RW; Bellomo R; Henderson SJ; Mackle DM; McArthur CJ; Mehrtens JE; Myburgh JA; McGuinness SP; Psirides AJ; Young PJ
    Crit Care Resusc; 2014 Dec; 16(4):274-9. PubMed ID: 25437221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative buffered versus non-buffered fluid administration for surgery in adults.
    Burdett E; Dushianthan A; Bennett-Guerrero E; Cro S; Gan TJ; Grocott MP; James MF; Mythen MG; O'Malley CM; Roche AM; Rowan K
    Cochrane Database Syst Rev; 2012 Dec; 12():CD004089. PubMed ID: 23235602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers.
    Chowdhury AH; Cox EF; Francis ST; Lobo DN
    Ann Surg; 2012 Jul; 256(1):18-24. PubMed ID: 22580944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fluid resuscitation with 0.9% saline versus a balanced electrolyte solution on acute kidney injury in a rat model of sepsis*.
    Zhou F; Peng ZY; Bishop JV; Cove ME; Singbartl K; Kellum JA
    Crit Care Med; 2014 Apr; 42(4):e270-8. PubMed ID: 24335444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balanced Crystalloids versus Saline in Noncritically Ill Adults.
    Self WH; Semler MW; Wanderer JP; Wang L; Byrne DW; Collins SP; Slovis CM; Lindsell CJ; Ehrenfeld JM; Siew ED; Shaw AD; Bernard GR; Rice TW;
    N Engl J Med; 2018 Mar; 378(9):819-828. PubMed ID: 29485926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte.
    Shaw AD; Bagshaw SM; Goldstein SL; Scherer LA; Duan M; Schermer CR; Kellum JA
    Ann Surg; 2012 May; 255(5):821-9. PubMed ID: 22470070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Plasma-Lyte 148 v Saline (PLUS) study protocol: a multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality.
    Hammond NE; Bellomo R; Gallagher M; Gattas D; Glass P; Mackle D; Micallef S; Myburgh J; Saxena M; Taylor C; Young P; Finfer S
    Crit Care Resusc; 2017 Sep; 19(3):239-246. PubMed ID: 28866974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balanced Crystalloids versus Saline in Critically Ill Adults.
    Semler MW; Self WH; Wanderer JP; Ehrenfeld JM; Wang L; Byrne DW; Stollings JL; Kumar AB; Hughes CG; Hernandez A; Guillamondegui OD; May AK; Weavind L; Casey JD; Siew ED; Shaw AD; Bernard GR; Rice TW;
    N Engl J Med; 2018 Mar; 378(9):829-839. PubMed ID: 29485925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.